Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 04, 2016
Greenphire, a global clinical payment technology company, has announced unprecedented year over year growth as a result of demand for its technology solutions from sponsors, CROs, universities, and hospitals looking to automate their payment ...
read more
Greenphire’s Patient Experience Dataset establishes the industry’s first repository of global patient-level insights by phase, therapeutic area, and country, including average stipends (where permitted) and reimbursements by categorical expense, ...
read more
Greenphire, a provider of global clinical payment solutions, has appointed Wayne Baker as Chief Commercial Officer to lead the commercial strategy of the rapidly growing organization worldwide.
read more
Monday, February 05, 2024
Greenphire, a provider of software solutions for streamlining clinical trials, announced the acquisition of Clincierge, a provider of concierge travel and logistics support for patients participating in clinical trials.
read more
GreenLight Biosciences and Samsung Bio announced the successful completion of their first commercial-scale mRNA engineering run.
read more
Wednesday, April 17, 2019
Greenfield Global has announced plans to establish a new EU manufacturing headquarters in Portlaoise, Ireland.
read more
Great Point Partners, an investment firm focused exclusively on the health care industry, announced the acquisition of Lyocontract GmbH (“Lyocontract”), a premium independent drug product contract development and manufacturing organization (“CDMO”) ...
read more
Granules announced the U.S. FDA has approved its Abbreviated New Drug Applications for Methylergonovine 0.2 mg tablets.
read more
Granules voluntarily recalling 12 lots of Metformin Hydrochloride Extended-Release Tablets due to the detection of NDMA levels above the Acceptable Daily Intake Limit.
read more
Grand River Aseptic Manufacturing has announced its second equipment purchase this year: a state-of-the-art Bausch+Ströbel fully integrated high-speed filling line with SKAN isolator.
read more
Tuesday, September 02, 2025
Grand River Aseptic Manufacturing announced the promotion of Denis Johnson to Chief Executive Officer, effective September 1, 2025. Mr. Johnson has served as President of GRAM since March 31, 2025.
read more
Grand River Aseptic Manufacturing has implemented its fully-automated serialization and aggregation processes for commercial injectable drug products.
read more
Grand River Aseptic Manufacturing has signed a multi-year contract with the U.S. Department of Health and Human Services and the U.S. Department of Defense. Under the agreement, GRAM will invest $160 million and receive $120 million from the U.S. ...
read more
Grand River Aseptic Manufacturing (GRAM) announced that Bernie King has been appointed Chief Operating Officer, a new position within GRAM. King will report to Tom Ross, President and CEO of GRAM.
read more
Grand River Aseptic Manufacturing expands its capabilities in syringe filling at its FDA-inspected, cGMP-compliant manufacturing facility in Grand Rapids, Mich.
read more